20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Method of managing joint pain
#1202Reconstitutable teverelix-TFA composition
#1203Method for treating cancer using dengue virus serotype 1 (DENV-1)
#1204Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same
#1205DANTROLENE FORMULATIONS AND METHODS OF THEIR USE
#1206Pharmaceutical formulations
#1207PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
#1208Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same
#1209BUSULFAN COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#1210Formulation and process for modulating wound healing
#1211Process for making dry and stable hemostatic compositions
#1212Methods and compositions for the treatment of C. difficile
#1213PEPTIDE/PARTICLE DELIVERY SYSTEMS
#1214Polymer excipients for drug delivery applications
#1215Compositions and uses thereof for treating disease or condition
#1216Formulations of SN-38 with poly(amino acid) block polymers
#1217Compositions of ixabepilone
#1218Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yljcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
#1219Wearable device and method for visual image adjustment
#1220PROCESS TO REDUCE ENDOTOXIN IN GELATIN
#1221Antibodies to symmetrically dimethylated arginine analytes and use thereof
#1222CSF-1R ANTIBODY FORMULATION
#1223LIPOSOMAL ANTICANCER COMPOSITIONS
#1224Method for preparing protein peptide based on connective tissue and prepared protein peptide and use thereof
#1225Liquid pharmaceutical composition
#1226COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1227LYOPHILIZED FORMULATION SEALED IN GLASS CONTAINER
#1228AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
#1229Lyophilized preparation
#1230Pharmaceutical compositions and uses thereof
#1231PHARMACEUTICAL FORMULATION
#1232NOVEL PENTOSAN POLYSULFATE SODIUM PREPARATION
#1233FREEZE-DRIED ALGINIC ACID PREPARATION
#1234Freeze-drying methods and related products
#1235Near infrared fluorescent dyes, formulations and related methods
#1236STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE
#1237Cariprazine release formulations
#1238Method for preparing organic solvent-free lyophilized cyclophosphamide
#1239Carbon quantum dots and preparation process and use thereof
#1240Endoxifen methods and compositions for inhibition of protein kinase C
#1241Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#1242PHARMACEUTICAL COMPOSITIONS WITH REDUCED TERT-BUTANOL LEVELS
#1243METHOD OF LYOPHILIZING LIPOSOMES
#1244MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT
#1245Oral compositions comprising methylprednisolone sodium succinate
#1246FREEZE-DRIED FORMULATIONS OF ANTIBACTERIAL PROTEIN
#1247Therapeutic constructs for treating cancer
#1248Display device having conductive spacers connecting anode and cathode on opposing substrates
#1249Method of preparing a faecal microbiota sample
#1250Compounds and compositions for treating solid tumors by intratumoral administration
#1251Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#1252Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
#1253Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#1254PHARMACEUTICAL COMPOSITIONS FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY
#1255Composition of lactobacillus and berry extract
#1256Freeze-dried formulations including nanoparticles and methods of freeze-drying
#1257Compositions comprising bacterial strains
#1258COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF
#1259Pharmaceutical composition for intraarticular delivery
#1260LIPOPHILIC ACTIVE AGENT INFUSED COMPOSITIONS WITH REDUCED FOOD EFFECT
#1261Antibodies to symmetrically dimethylated arginine analytes and use thereof
#1262SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS
#1263Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate
#1264Manufacture of degarelix
#1265Microbiota restoration therapy (MRT) compositions and methods of manufacture
#1266Microbiota restoration therapy (MRT) compositions and methods of manufacture
#1267Drug combination for treatment of amyotrophic lateral sclerosis, preparation method and use thereof
#1268SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
#1269ANTIBODY-DRUG CONJUGATE PREPARATION AND LYOPHILIZATION FOR SAME
#1270Dosing regimens for echinocandin class compounds
#1271Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease
#1272Antiviral methods and compositions comprising probiotic bacterial molecules
#1273COMPOSITION FOR PROMOTING GLUCOLIPID METABOLISM, AND PREPARATION AND APPLICATION THEREOF
#1274Radiation-Sterilized Biodegradable Drug Delivery Compositions
#1275INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#1276DRUG DELIVERY SYSTEMS
#1277Pharmaceutical compositions of IL-2
#1278Method for freeze-drying cells in a hydrogel comprising nanofibrillar cellulose and freeze-dried cells in an aerogel comprising nanofibrillar cellulose
#1279Protein formulations and methods of making same
#1280LIQUID PHARMACEUTICAL COMPOSITION
#1281METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D)
#1282COMBINATION THERAPY WITH TARGETED TGF-B INHIBITION FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
#1283IMPROVED METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#1284Protein formulations and methods of making same
#1285FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS
#1286Formula of neuregulin preparation
#1287Stabilized Composition
#1288Annelid haemoglobin lyophilisation process
#1289COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#1290Pharmaceutical composition comprising plasminogen and uses thereof
#1291STABILIZED STATIN FORMULATIONS
#12926-pyrimidin-isoindole derivative as ERK1/2 inhibitor
#1293USE OF PLATELETS IN TREATING INFECTIONS
#1294STABLE LYOPHILIZED COMPOSITION OF CYCLOPHOSPHAMIDE
#1295Compositions for the treatment of drug-resistant tumors and methods of use thereof
#1296PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF
#1297Placental tissue component compositions for treatment of skin defects and methods using same
#1298Liquid Protein Formulations Containing Viscosity-Lowering Agents
#1299Preparation and application of grain worm for treating diabetes
#1300Lyophilized compositions of phenobarbital sodium salt
#1301Citrate buffered VEGF antagonist formulations
#1302Manufacture of Degarelix
#1303compositions and methods of use with ruminants
#1304Formulations Having Anti-inflammatory Activity and Antimicrobial Activity Against Gram-Positive Bacteria
#1305Antibody Formulations and Methods
#1306COMPOSITION AND METHOD FOR FREEZE-DRYING PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG
#1307Biodegradable polymer microsphere compositions for parenteral administration
#1308ANTIBODY AND PROTEIN FORMULATIONS
#1309PHARMACEUTICAL FORMULATIONS
#1310VLP stabilized vaccine compositions
#1311Lyophilized factor IX formulations
#1312Methods for the isolation of microbes with enhanced persistance and compositions with such microbes
#1313COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1314Methods of making novel pharmaceutical compositions
#1315Composition containing piperacillin, pharmaceutical formulation thereof and use thereof
#1316High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#1317Manufacturing method of an herbal medicinal tablet formulation for treating obesity which can be prescribed based on sasang constitutional medicine
#1318Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease
#1319Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#1320Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#1321Compositions comprising bacterial species and methods related thereto
#1322Compositions and methods for treatment
#1323Pharmaceutical composition comprising particles and methods of making same
#1324Method for producing freeze-dried formulation
#1325Hydrophobic molecule-induced branched polymer aggregates and their use
#1326Dry Transfection Compositions and Methods for Making and Using the Same
#1327HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#1328Methods for treatment using anti-alpha4beta7 antibody
#1329ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#1330Bacterial strain useful for treatment of age-related conditions
#1331Compositions comprising bacterial strains
#1332COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#1333Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
#1334Methods of supporting a graphene sheet disposed on a frame support
#1335Nanoparticle compositions
#1336Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
#1337Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
#1338Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
#1339Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#1340Cochleates made with soy phosphatidylserine
#1341Method for stabilizing a toxin
#1342Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)
#1343Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein
#1344Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)
#1345Liquid pharmaceutical composition
#1346Intestinal alkaline phosphatase formulations
#1347Dry powder composition comprising long-chain RNA
#1348Antibodies to symmetrically dimethylated arginine analytes and use thereof
#1349Pharmaceutical composition for treating cancer
#1350Composition for treating brain stroke
#1351CANNABINOID-CONTAINING COMPOSITIONS IN THE FORM OF SPHERES OR SPHERE-LIKE PARTICLES, METHODS FOR THEIR PREPARATION, AND THERAPEUTIC APPLICATIONS
#1352Composition and methods for stabilizing liquid protein formulations
#1353TREATMENT USING DANTROLENE
#1354FREEZE-DRIED MULTIPARTICULATE SOLID DOSAGE FORM
#1355Method for lyophilizing live vaccine strains of
#1356ENHANCED OSTEOGENIC COMPOSITION
#1357Remote loading of sparingly water-soluble drugs into lipid vesicles
#1358NANOPARTICLE COMPOSITIONS
#1359Compositions for stabilizing and delivering proteins
#1360STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF IN MEDICINE
#1361Peptide Conjugated Particles
#1362Anti-Stress Composition
#1363Polymer particles for neutrophil injury
#1364Immunotoxins, formulations thereof and their use in medicine
#1365LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB
#1366Methods and compositions for CNS delivery of arylsulfatase A
#1367NEW USE OF MICROBIOLOGICAL COMPOSITIONS
#1368PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF
#1369Anti-CD38 antibodies and formulations
#1370Pyrazolopyrimidine inhibitors of JAK kinases and uses thereof
#1371Anti-CD40 antibody formulation delivery device
#1372Pharmaceutical composition, package and method for producing the same
#1373Long lasting effect of new botulinum toxin formulations
#1374Reconstituted HDL formulation
#1375Package and method for producing the same
#1376Pharmaceutical compositions
#1377Drug delivery system and method for the treatment of neuro-degenerative disease
#1378Methods for treating systemic sclerosis
#1379FORMULATIONS OF DENGUE VIRUS VACCINE COMPOSITIONS
#1380Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant
#1381Rusalatide acetate compositions
#1382Pharmaceutical formulations of C1 esterase inhibitor
#1383METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#1384CUSTOMIZABLE CANNABINOID POWDER AND PRODUCTION METHODS
#1385Stable Dual Variable Domain Immunoglobulin Protein Formulations
#1386Pharmaceutically acceptable salts of polypeptides and methods of inhibiting the interaction between psd-95 and n-methyl-d-aspartic acid receptor (nmdar)
#1387Saposin C pharmaceutical compositions and methods of treating cancer
#1388LIQUID IL-1 BETA ANTIBODY FORMULATION HAVING PH OF 5.5 TO 7.0
#1389Chloride salt of TAT-NR2B9C
#1390Compositions comprising bacterial strains
#1391Lyophilization of RNA
#1392Stabilized liquid and lyophilized ADAMTS13 formulations
#1393PROBIOTIC RECOLONISATION THERAPY
#1394Diketopiperazine microparticles with defined specific surface areas
#1395Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
#1396Energy recovery in a freeze-drying system
#1397Cyclodextrin-panobinostat adduct
#1398METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE
#1399Extracts for the regeneration of ligaments
#1400Stable lyophilisates comprising 5,10-methylene-(6R)-tetrahydrofolic acid
#1401Vaccine delivery systems using yeast cell wall particles
#1402A LIPID NANOPARTICLE COMPOSITION AND A PHARMACEUTICAL COMPOSITION FOR TREATING A HEMATOPROLIFERATIVE DISORDER
#1403Lyophilized formulation of a monoclonal antibody against transthyretin
#1404Fructophilic lactic acid producing bacteria
#1405Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
#1406Chitosan materials from carbonic acid solution
#1407Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#1408FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
#1409Thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers
#1410Anti-folate receptor alpha antibody conjugated with hemiasterlins
#1411PHARMACEUTICAL COMPOSITIONS, METHODS FOR PREPARATION COMPRISING SIZING OF LIPID VESICLE PARTICLES, AND USES THEREOF
#1412Compositions comprising bacterial strains
#1413Compositions comprising bacterial strains
#1414Viral vector stabilization
#1415Viral vector stabilization
#1416Process for the preparation of powdered probiotic formulations for monogastric animals
#1417Excipients to reduce the viscosity of antibody formulations and formulation compositions
#1418Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#1419Lyophilized preparation of cytotoxic dipeptides
#1420Norovirus vaccine
#1421Pharmaceutical oral formulation comprising bacteria
#1422Compositions and formulations including cabazitaxel and human serum albumin
#1423Herbal medicinal tablet formulation for treating obesity which can be prescribed based on sasang constitutional medicine
#1424SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION
#1425PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#1426Use of chlorogenic acid in preparation of drug for treating chordoma
#1427Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations
#1428Pharmaceutical compositions for subcutaneous administration of levosimendan
#1429Method for lyophilizing exosome
#1430PSMA inhibitor derivatives for labelling with 99mTc via HYNIC, a radiopharmaceutical kit, radiopharmaceutical preparations and their use in prostate cancer diagnostics
#1431Compositions comprising bacterial strains
#1432NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
#1433Formulations for pharmaceutical agents
#1434Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient
#1435Antibodies to symmetrically dimethylated arginine analytes and use thereof
#1436POLYPEPTIDES
#1437Crystalline forms of a biphenyl compound
#1438Peptide conjugated particles
#1439Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
#1440STABILIZED STATIN FORMULATIONS
#1441MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME
#1442Carrier-binding agent compositions and methods of making and using the same
#1443COMPOSITIONS AND METHODS FOR STABILIZING ALPHAVIRUSES WITH IMPROVED FORMULATIONS
#1444Solid dispersion
#1445Methods of making lipid nanoparticles
#1446Freeze-dried composition
#1447Lyophilized formulations for factor Xa antidote
#1448LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
#1449PHARMACEUTICAL COMPOSITION COMPRISING PEGYLATED FAB' FRAGMENT OF ANTI-HUMAN NGF ANTIBODY
#1450Process for Manufacturing Stable Epinephrine
#1451All-in-one lyophilized multivitamin emulsion for parenteral application
#1452System and method for image generation based on a display-attachable wearable device
#1453Drug delivery system containing phospholipid and cholesterol
#1454Isolation, preservation, compositions and uses of extracts from justicia plants
#1455Oncolytic herpes simplex virus infected cells
#1456Combination product for prophylaxis and treatment of irritable bowel syndrome
#1457Compositions and Methods for the Treatment of Metabolic Conditions
#1458COMPOSITION FOR TREATING INTERVERTEBRAL DISC
#1459SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION
#1460COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS
#1461DEVICE, METHOD AND FORMULATION FOR CHEMICALLY ASSISTED DISSECTION
#1462FORMULATIONS OF MONOCLONAL ANTIBODIES
#1463Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#1464PSMA targeted fluorescent agents for image guided surgery
#1465ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS
#1466Pharmaceutical composition of docetaxel conjugate and preparation method
#1467Anti-IL-36R antibody formulations
#1468FORMULATIONS OF COPANLISIB
#1469System and method for freeze-drying and packaging
#1470Pharmaceutical Formulations
#1471Catalyst for the regeneration of tissues and related method for making it
#1472PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS
#1473Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#1474Bioavailable dithiocarbamate-metal complex particles, method of preparation and use thereof
#1475Pharmaceutical compositions for intraarticular delivery
#1476bacterium for treatment of e.g. bacterial vaginosis
#1477Compositions comprising bacterial strains
#1478Therapeutic compositions
#1479CABAZITAXEL COMPOSITION FOR INJECTION AND PREPARATION METHOD THEREFOR
#1480Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
#1481EXPRESSION AND FOLDING IN THE MANUFACTURING PROCESS OF CD-RAP BY USING A CD-RAP PRECURSOR PROTEIN
#1482Compositions and methods for treating hepatic fibrosis
#1483Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
#1484DOTMP kit formulations for radioisotopes
#1485Factor IX polypeptide formulations
#1486Dry growth hormone composition transiently linked to a polymer carrier
#1487Composite probiotics and use thereof
#1488Compositions and methods for lyophilization of bacteria or listeria strains
#1489Targeted hydrophobic anti-tumor drug nanoformulation and preparation method thereof
#1490COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
#1491Compositions and methods for the induction of CD8+ T-cells
#1492Stabilised Solid Compositions of Factor VII Polypeptides
#1493Thermostable Composition Having Antiviral and Antibacterial Activity and the Use Thereof
#1494Daptomycin formulations
#1495Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
#1496CRAC CHANNEL INHIBITOR COMPOSITIONS
#1497Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#1498ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION
#1499Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#1500Use of C-type natriuretic peptide variants to treat skeletal dysplasia